BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shi C, Wu H, Xu K, Cai T, Qin K, Wu L, Cai B. Liquiritigenin-Loaded Submicron Emulsion Protects Against Doxorubicin-Induced Cardiotoxicity via Antioxidant, Anti-Inflammatory, and Anti-Apoptotic Activity. Int J Nanomedicine 2020;15:1101-15. [PMID: 32110010 DOI: 10.2147/IJN.S235832] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Yuan H, Xue Y. To Explore the Key Active Compounds and Therapeutic Mechanism of Guizhi Gancao Decoction in Coronary Heart Disease by Network Pharmacology and Molecular Docking. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-15. [DOI: 10.1155/2022/2566407] [Reference Citation Analysis]
2 Assali M, Jaradat N, Maqboul L. The Formation of Self-Assembled Nanoparticles Loaded with Doxorubicin and d-Limonene for Cancer Therapy. ACS Omega 2022. [DOI: 10.1021/acsomega.2c04238] [Reference Citation Analysis]
3 Zhang M, Qi J, He Q, Ma D, Li J, Chu X, Zuo S, Zhang Y, Li L, Chu L. Liquiritigenin protects against myocardial ischemic by inhibiting oxidative stress, apoptosis, and L-type Ca2+ channels. Phytother Res 2022. [PMID: 35747908 DOI: 10.1002/ptr.7528] [Reference Citation Analysis]
4 Neto JC, Paulino ET, Rodrigues AKBF, Silva JCGD, Bernardino AC, Oliveira JMDS, Nascimento TGD, Oliveira WDS, Santos JCC, Smaniotto S, Ribeiro ÊAN. Cardioprotective effect of hydroalcoholic extract of Brazilian red propolis against isoproterenol-induced myocardial infarction in rats. Phytomedicine Plus 2022;2:100190. [DOI: 10.1016/j.phyplu.2021.100190] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Lu D, Huang Y, Ma W, Chen C, Hou L. Jin-Wu-Jian-Gu Formulation Attenuates Rheumatoid Arthritis by Inhibiting the IL33-ST2 Signaling Pathway. Evid Based Complement Alternat Med 2022;2022:6821388. [PMID: 35096114 DOI: 10.1155/2022/6821388] [Reference Citation Analysis]
6 Na S, Ying L, Jun C, Ya X, Suifeng Z, Yuxi H, Jing W, Zonglang L, Xiaojun Y, Yue W. Study on the molecular mechanism of nightshade in the treatment of colon cancer. Bioengineered 2022;13:1575-89. [PMID: 35012428 DOI: 10.1080/21655979.2021.2016045] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
7 Xu Z, Hu Z, Xu H, Zhang L, Li L, Wang Y, Zhu Y, Yang L, Hu D. Liquiritigenin alleviates doxorubicin-induced chronic heart failure via promoting ARHGAP18 and suppressing RhoA/ROCK1 pathway. Exp Cell Res 2022;411:113008. [PMID: 34990617 DOI: 10.1016/j.yexcr.2022.113008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Zhang M, Xue Y, Zheng B, Li L, Chu X, Zhao Y, Wu Y, Zhang J, Han X, Wu Z, Chu L. Liquiritigenin protects against arsenic trioxide-induced liver injury by inhibiting oxidative stress and enhancing mTOR-mediated autophagy. Biomed Pharmacother 2021;143:112167. [PMID: 34560535 DOI: 10.1016/j.biopha.2021.112167] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
9 Chen J, Qian C, Ren P, Yu H, Kong X, Huang C, Luo H, Chen G. Light-Responsive Micelles Loaded With Doxorubicin for Osteosarcoma Suppression. Front Pharmacol 2021;12:679610. [PMID: 34220512 DOI: 10.3389/fphar.2021.679610] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Lee HS, Kim EN, Jeong GS. Oral Administration of Liquiritigenin Confers Protection from Atopic Dermatitis through the Inhibition of T Cell Activation. Biomolecules 2020;10:E786. [PMID: 32438694 DOI: 10.3390/biom10050786] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]